SEARCH

SEARCH BY CITATION

References

  • 1
    Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001; 1: 2233.
  • 2
    Leibeling D,Laspe P,Emmert S. Nucleotide excision repair and cancer. J Mol Histol 2006; 37: 22538.
  • 3
    Bai Y,Xu L,Yang X,Hu Z,Yuan J,Wang F,Shao M,Yuan W,Qian J,Ma H,Wang Y,Liu H, et al. Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: a case-control study. BMC Cancer 2007; 7: 81.
  • 4
    Butkiewicz D,Popanda O,Risch A,Edler L,Dienemann H,Schulz V,Kayser K,Drings P,Bartsch H,Schmezer P. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene. Cancer Epidemiol Biomarkers Prev 2004; 13: 22426.
  • 5
    Butkiewicz D,Rusin M,Enewold L,Shields PG,Chorazy M,Harris CC. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 2001; 22: 5937.
  • 6
    Chen S,Tang D,Xue K,Xu L,Ma G,Hsu Y,Cho SS. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 2002; 23: 13215.
  • 7
    Cui Y,Morgenstern H,Greenland S,Tashkin DP,Mao J,Cao W,Cozen W,Mack TM,Zhang ZF. Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer 2006; 118: 71420.
  • 8
    David-Beabes GL,Lunn RM,London SJ. No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 91112.
  • 9
    De Ruyck K,Szaumkessel M,De Rudder I,Dehoorne A,Vral A,Claes K,Velghe A,Van Meerbeeck J,Thierens H. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res 2007; 631: 10110.
  • 10
    Harms C,Salama SA,Sierra-Torres CH,Cajas-Salazar N,Au WW. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 2004; 44: 7482.
  • 11
    Hou SM,Falt S,Angelini S,Yang K,Nyberg F,Lambert B,Hemminki K. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002; 23: 599603.
  • 12
    Hu Z,Wang Y,Wang X,Liang G,Miao X,Xu Y,Tan W,Wei Q,Lin D,Shen H. DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int J Cancer 2005; 115: 47883.
  • 13
    Hu Z,Xu L,Shao M,Yuan J,Wang Y,Wang F,Yuan W,Qian J,Ma H,Wang Y,Liu H,Chen W, et al. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population. Cancer Epidemiol Biomarkers Prev 2006; 15: 133640.
  • 14
    Jeon HS,Kim KM,Park SH,Lee SY,Choi JE,Lee GY,Kam S,Park RW,Kim IS,Kim CH,Jung TH,Park JY. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 2003; 24: 167781.
  • 15
    Landi S,Gemignani F,Canzian F,Gaborieau V,Barale R,Landi D,Szeszenia-Dabrowska N,Zaridze D,Lissowska J,Rudnai P,Fabianova E,Mates D, et al. DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res 2006; 66: 110629.
  • 16
    Lee GY,Jang JS,Lee SY,Jeon HS,Kim KM,Choi JE,Park JM,Chae MH,Lee WK,Kam S,Kim IS,Lee JT, et al. XPC polymorphisms and lung cancer risk. Int J Cancer 2005; 115: 80713.
  • 17
    Liang G,Xing D,Miao X,Tan W,Yu C,Lu W,Lin D. Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int J Cancer 2003; 105: 66973.
  • 18
    Matullo G,Dunning AM,Guarrera S,Baynes C,Polidoro S,Garte S,Autrup H,Malaveille C,Peluso M,Airoldi L,Veglia F,Gormally E, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006; 27: 9971007.
  • 19
    Michiels S,Danoy P,Dessen P,Bera A,Boulet T,Bouchardy C,Lathrop M,Sarasin A,Benhamou S. Polymorphism discovery in 62 DNA repair genes and haplotype-associations with risks for lung, and head and neck cancers. Carcinogenesis 2007; 28: 17319.
  • 20
    Misra RR,Ratnasinghe D,Tangrea JA,Virtamo J,Andersen MR,Barrett M,Taylor PR,Albanes D. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and. APE/ref-1, and the risk of lung cancer among male smokers in. Finland. Cancer Lett 2003; 191: 1718.
  • 21
    Park JY,Lee SY,Jeon HS,Park SH,Bae NC,Lee EB,Cha SI,Park JH,Kam S,Kim IS,Jung TH. Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer (Amsterdam, Netherlands) 2002; 36: 1516.
  • 22
    Park JY,Park SH,Choi JE,Lee SY,Jeon HS,Cha SI,Kim CH,Park JH,Kam S,Park RW,Kim IS,Jung TH. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 9937.
  • 23
    Popanda O,Schattenberg T,Phong CT,Butkiewicz D,Risch A,Edler L,Kayser K,Dienemann H,Schulz V,Drings P,Bartsch H,Schmezer P. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004; 25: 243341.
  • 24
    Sakiyama T,Kohno T,Mimaki S,Ohta T,Yanagitani N,Sobue T,Kunitoh H,Saito R,Shimizu K,Hirama C,Kimura J,Maeno G, et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53. POLI, REV1 and. LIG4 with lung cancer risk. Int J Cancer 2005; 114: 7307.
  • 25
    Shen H,Spitz MR,Qiao Y,Zheng Y,Hong WK,Wei Q. Polymorphism of DNA ligase I and risk of lung cancer–a case-control analysis. Lung Cancer (Amsterdam,Netherlands) 2002; 36: 2437.
  • 26
    Shen M,Berndt SI,Rothman N,Demarini DM,Mumford JL,He X,Bonner MR,Tian L,Yeager M,Welch R,Chanock S,Zheng T, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 2005; 116: 76873.
  • 27
    Sobti RC,Kaur P,Kaur S,Janmeja AK,Jindal SK,Kishan J,Raimondi S. No association of DNA ligase-I polymorphism with the risk of lung cancer in north-Indian population. DNA Cell Biol 2006; 25: 4849.
  • 28
    Spitz MR,Wu X,Wang Y,Wang LE,Shete S,Amos CI,Guo Z,Lei L,Mohrenweiser H,Wei Q. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61: 13547.
  • 29
    Vogel U,Laros I,Jacobsen NR,Thomsen BL,Bak H,Olsen A,Bukowy Z,Wallin H,Overvad K,Tjonneland A,Nexo BA,Raaschou-Nielsen O. Two regions in chromosome 19q13.2–3 are associated with risk of lung cancer. Mutat Res 2004; 546: 6574.
  • 30
    Vogel U,Overvad K,Wallin H,Tjonneland A,Nexo BA,Raaschou-Nielsen O. Combinations of polymorphisms in XPD, XPC and. XPA in relation to risk of lung cancer. Cancer Lett 2005; 222: 6774.
  • 31
    Wu X,Zhao H,Wei Q,Amos CI,Zhang K,Guo Z,Qiao Y,Hong WK,Spitz MR. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 2003; 24: 5059.
  • 32
    Xing D,Tan W,Wei Q,Lin D. Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer (Amsterdam, Netherlands) 2002; 38: 1239.
  • 33
    Yin J,Li J,Ma Y,Guo L,Wang H,Vogel U. The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population. Cancer Lett 2005; 223: 21926.
  • 34
    Yin J,Li J,Vogel U,Wang H. Polymorphisms of DNA repair genes: ERCC1 G19007A and ERCC2/XPD C22541A in a northeastern Chinese population. Biochem Genet 2005; 43: 5438.
  • 35
    Yin J,Vogel U,Guo L,Ma Y,Wang H. Lack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese population. Cancer Genet Cytogenet 2006; 164: 6670.
  • 36
    Yin J,Vogel U,Ma Y,Guo L,Wang H,Qi R. Polymorphism of the DNA repair gene ERCC2 Lys751Gln and risk of lung cancer in a northeastern Chinese population. Cancer Genet Cytogenet 2006; 169: 2732.
  • 37
    Yin J,Vogel U,Ma Y,Qi R,Sun Z,Wang H. A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population. Cancer Genet Cytogenet 2007; 175: 4751.
  • 38
    Zhou W,Liu G,Miller DP,Thurston SW,Xu LL,Wain JC,Lynch TJ,Su L,Christiani DC. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 2002; 62: 137781.
  • 39
    Zhou W,Liu G,Miller DP,Thurston SW,Xu LL,Wain JC,Lynch TJ,Su L,Christiani DC. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 35965.
  • 40
    Zhou W,Liu G,Park S,Wang Z,Wain JC,Lynch TJ,Su L,Christiani DC. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 4916.
  • 41
    Zienolddiny S,Campa D,Lind H,Ryberg D,Skaug V,Stangeland L,Phillips DH,Canzian F,Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006; 27: 5607.
  • 42
    Chyou PH,Nomura AM,Stemmermann GN. A prospective study of the attributable risk of cancer due to cigarette smoking. Am J Public Health 1992; 82: 3740.
  • 43
    Haiman CA,Stram DO,Wilkens LR,Pike MC,Kolonel LN,Henderson BE,Le Marchand L. Ethnic and racial differences in the smoking-related risk of lung cancer. New Engl J Med 2006; 354: 33342.
  • 44
    Pinsky PF. Racial and ethnic differences in lung cancer incidence: how much is explained by differences in smoking patterns? (United States). Cancer Causes Control 2006; 17: 101724.
  • 45
    Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute, NCI. Available at http://seer.cancer.gov (accessed on June 19, 2007).
  • 46
    Thomas DC,Witte JS. Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 2002; 11: 50512.
  • 47
    Cabral DN,Napoles-Springer AM,Miike R,McMillan A,Sison JD,Wrensch MR,Perez-Stable EJ,Wiencke JK. Population- and community-based recruitment of African Americans and Latinos: the San Francisco bay area lung cancer study. Am J Epidemiol 2003; 158: 2729.
  • 48
    Caggana M,Kilgallen J,Conroy JM,Wiencke JK,Kelsey KT,Miike R,Chen P,Wrensch MR. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev 2001; 10: 35560.
  • 49
    Hu Z,Wei Q,Wang X,Shen H. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer (Amsterdam, Netherlands) 2004; 46: 110.
  • 50
    King CR,Yu J,Freimuth RR,McLeod HL,Marsh S. Interethnic variability of ERCC2 polymorphisms. Pharmacogenomics J 2005; 5: 549.
  • 51
    Mohrenweiser HW,Xi T,Vazquez-Matias J,Jones IM. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev 2002; 11: 105464.
  • 52
    Packer BR,Yeager M,Burdett L,Welch R,Beerman M,Qi L,Sicotte H,Staats B,Acharya M,Crenshaw A,Eckert A,Puri V, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006; 34: D61721.
  • 53
    The International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 78996.
  • 54
    Wiemels JL,Wiencke JK,Kelsey KT,Moghadassi M,Rice T,Urayama KY,Miike R,Wrensch M. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev 2007; 16: 122935.
  • 55
    Chakraborty R,Weiss KM. Frequencies of complex diseases in hybrid populations. Am J Phys Anthropol 1986; 70: 489503.
  • 56
    Hanis CL,Chakraborty R,Ferrell RE,Schull WJ. Individual admixture estimates: disease associations and individual risk of diabetes and gallbladder disease among Mexican-Americans in Starr County, Texas. Am J Phys Anthropol 1986; 70: 43341.
  • 57
    Hansen HM,Wiemels JL,Wrensch M,Wiencke JK. DNA quantification of whole genome amplified samples for genotyping on a multiplexed bead array platform. Cancer Epidemiol Biomarkers Prev 2007; 16: 168690.
  • 58
    Wacholder S,Chanock S,Garcia-Closas M,El Ghormli L,Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96: 43442.
  • 59
    Barrett JC,Fry B,Maller J,Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England). 2005; 21: 2635.
  • 60
    Gabriel SB,Schaffner SF,Nguyen H,Moore JM,Roy J,Blumenstiel B,Higgins J,DeFelice M,Lochner A,Faggart M,Liu-Cordero SN,Rotimi C, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 22259.
  • 61
    Clayton D. SNPHAP. [Internet] 2008 [cited 2008 May 8]. Available from: http://www-gene.cimr.cam.ac.uk/clayton/software/snphap.txt.
  • 62
    Adkins RM. Comparison of the accuracy of methods of computational haplotype inference using a large empirical dataset. BMC Genet 2004; 5: 22.
  • 63
    Kraft P,Cox DG,Paynter RA,Hunter D,De Vivo I. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 2005; 28: 26172.
  • 64
    Zaykin DV,Westfall PH,Young SS,Karnoub MA,Wagner MJ,Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 53: 7991.
  • 65
    Ritchie MD,Hahn LW,Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003; 24: 1507.
  • 66
    Ritchie MD,Hahn LW,Roodi N,Bailey LR,Dupont WD,Parl FF,Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001; 69: 13847.
  • 67
    Gauderman WJ,Murcray C,Gilliland F,Conti DV. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 2007; 31: 38395.
  • 68
    Kiyohara C,Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci 2007; 4: 5971.
  • 69
    Wolfe KJ,Wickliffe JK,Hill CE,Paolini M,Ammenheuser MM,Abdel-Rahman SZ. Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression. Pharmacogenet. Genomics 2007; 17: 897905.
  • 70
    Laine JP,Mocquet V,Bonfanti M,Braun C,Egly JM,Brousset P. Common XPD (ERCC2) polymorphisms have no measurable effect on nucleotide excision repair and basal transcription. DNA Repair (Amst) 2007; 6: 126470.